WHO Collaborating Centres
Global database
Version 1.5
Search / List / Details
Ref.No. [Initiator]
UNK-133 [Headquarters]
Status
Active
Title of the centre:
  WHO Collaborating Centre for Laboratory and Diagnostic Support

Director / Head: 
  Professor John PARRY
 




Institution:
  Human Papillomavirus Virus (HPV) & Hepatis C Virus (HCV) Unit, Virus Reference Department
  Public Health England (PHE)
Address:
  61 Colindale Avenue
  NW9 5HT
 
Town:
  London
Country:
  UK
Region:
  EURO
Phone:
  +442083276208
Fax:
  +442082001569
Date of Designation:
  01/May/1986
Last Redesignation:
  17/Jul/2009
Expiry:
  17/Jul/2013
Terms of Reference:
  1. 1. To advise on surveillance of retrovirus diseases, in particular HIV & HTLVI/II, hepatitis viruses & other infections. 
  2. 2. To design & participate in WHO collaborating studies related to the performance of diagnostic technologies for detection of hepatitis & retroviruses. 
  3. 3. To provide laboratory reference services in consultation with WHO. 
  4. 4. To act as a repository for the WHO Hepatitis B & Hepatitis C panels. 
  5. 5. To advise on serological & nuclei acid testing systems for HIV, Hepatitis B, Hepatitis C, HTLVI/II & other infections such as malaria. 
  6. 6. To provide reference panels of sera & quality control samples. 
  7. 7. To advise on the production of working reagents including quality control samples & good laboratory practice. 
  8. 8. To provide guidance related to testing strategies. 9. To train laboratory & public health personnel on behalf of WHO.  
  9.  
  10.  
Subjects:
  1. Health Technology (including laboratory services; but excluding blood safety) 
  2. HIV/AIDS 
  3. Hepatitis 
Types of activity:
  1. Provision of reference substances and other services 
  2. Research 
  3. Training and education 
WHO organization wide expected result:
  11.2 - International norms, standards and guidelines for the quality, safety, efficacy and cost effective use of medical products and technologies developed and their national and/or regional implementation advocated and supported.
  11.3 - Evidence based policy guidance on promoting scientifically sound and cost-effective use of medical products and technologies by health workers and consumers developed and supported within the Secretariat and regional and national programmes.
  2.2 - Policy and technical support provided to countries towards expanded gender-sensitive delivery of prevention, treatment and care interventions for HIV/AIDS, tuberculosis and malaria, including integrated training and service delivery; wider service-provider networks; and strengthened laboratory capacities and better linkages with other health services, such as those for sexual and reproductive health, maternal, newborn and child health, sexually transmitted infections, nutrition, drug-dependence treatment service respiratory care, neglected diseases and environmental health.
Responsible Officer:
  VERCAUTEREN Gaby Henriette
Phone:
  +41 22 79 14728

Technical Counterpart:
  HOFMANN Thomas Dieter
Phone:
  +45 39171440
Email:
  hof@euro.who.int
Access to annual progress reports and the current workplan (this is accessible to WHO Staff Members only):
  Link to eWork